Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-21
DOI
10.1038/s41598-018-30072-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clustered localization of EGFRvIII in glioblastoma cells as detected by high precision localization microscopy
- (2016) Philip S. Boyd et al. Nanoscale
- Viral manipulation of the host immune response
- (2015) Allison Christiaansen et al. CURRENT OPINION IN IMMUNOLOGY
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells
- (2014) J. Carrasco et al. JOURNAL OF IMMUNOLOGY
- Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma
- (2014) M. Fujita et al. JOURNAL OF IMMUNOLOGY
- Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model
- (2014) Xuan Wang et al. TUMOR BIOLOGY
- Tumor microenviroment and hepatocellular carcinoma metastasis
- (2013) Hongyang Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Engineering effective T-cell based antitumor immunity
- (2013) Thomas Gruber et al. OncoImmunology
- Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors
- (2012) A. M. Donson et al. JOURNAL OF IMMUNOLOGY
- Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion
- (2012) Qian Wu et al. Molecular Cancer
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein
- (2011) Gao Huile et al. BIOMATERIALS
- A GPR40 Agonist GW9508 Suppresses CCL5, CCL17, and CXCL10 Induction in Keratinocytes and Attenuates Cutaneous Immune Inflammation
- (2011) Tomoko Fujita et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Advances in the Treatment of Malignant Gliomas
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10
- (2009) Mitsugu Fujita et al. CANCER RESEARCH
- Human Regulatory T Cell Suppressive Function Is Independent of Apoptosis Induction in Activated Effector T Cells
- (2009) Yvonne Vercoulen et al. PLoS One
- TNF-α and the IFN-γ-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma
- (2008) M Enderlin et al. CANCER GENE THERAPY
- Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
- (2008) Mitomu Kioi et al. MOLECULAR CANCER THERAPEUTICS
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More